Skip to content
Home/Companies/MedTech/Advosense
Advosense

Advosense

MedTech·Germany·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Advosense?

Advosense is a German MedTech company, currently owned by Gruenderfonds Ruhr since 2020.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Gruenderfonds Ruhr
Investor
Gruenderfonds Ruhr
Gruenderfonds Ruhr I · 2017 · VC

Key facts

HQGermany
SectorMedTech
StatusActive
Websitewww.advosense.com

More from Gruenderfonds Ruhr I

Other portfolio companies in the same fund.

ekko
Active
SoftwareGermany· 2023
Lidrotec
Active
Deep TechGermany· 2022
Spherity
Spherity
Active
CybersecurityGermany· 2022
VMRay
VMRay
Active
CybersecurityGermany· 2022
Masterplan
Masterplan
Exited 2025
EdTechGermany· 2020
to Amadeus Fire
Abalos Therapeutics
Active
BiotechGermany· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Advosense?

Advosense is currently owned by Gruenderfonds Ruhr, through Gruenderfonds Ruhr I, since 2020.

When did Gruenderfonds Ruhr acquire Advosense?

Gruenderfonds Ruhr acquired Advosense in 2020.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue